Research use onlyFor laboratory and research purposes only — not for human consumption, medical, veterinary or diagnostic use.

PeptideStacks
methodology

YMYL content (E-E-A-T)

also: YMYL, Your Money or Your Life, E-E-A-T, EEAT, medical credibility SEO

Google's classification for content that materially impacts a reader's health, finances or safety — requiring demonstrable Experience, Expertise, Authority and Trust signals.

YMYL — "Your Money or Your Life" — is a classification Google uses in its Search Quality Rater Guidelines to identify web content that could materially affect a reader's health, financial stability, safety, or wellbeing. Pages discussing medical treatments, drug interactions, dietary protocols, legal advice, or financial decisions are canonical YMYL topics. Google applies heightened quality scrutiny to YMYL content, assessing it through the lens of E-E-A-T: Experience, Expertise, Authoritativeness, and Trustworthiness.

Why it matters in peptide research

Peptide research content sits squarely in the YMYL category. A reader who misunderstands a dosing protocol, confuses a regulated pharmaceutical with an unscheduled research compound, or acts on inaccurate safety information about a peptide could experience direct physical harm. Google's quality raters — human evaluators who assess search results quality — will apply YMYL scrutiny when reviewing any page discussing peptide pharmacology, administration protocols, or health outcomes, and algorithmic signals derived from rater feedback influence search ranking.

For a peptide-focused content site, E-E-A-T signals must be actively cultivated rather than assumed. Authoritativeness is built through author credential disclosure (ideally a named author with relevant scientific or medical background), citation of primary peer-reviewed literature rather than only secondary sources, and clear delineation of research context versus clinical practice. Trustworthiness is reinforced by transparent disclosure of the site's purpose, unambiguous disclaimer language, accurate representation of regulatory status for all compounds discussed, and balanced presentation that acknowledges limitations and gaps in the evidence base rather than promotional framing.

Experience — the first E added to the original E-A-T framework in 2022 — refers to demonstrating first-hand knowledge or direct engagement with the subject matter. For a research information site, this can mean documenting the research process, discussing methodological nuances, and engaging substantively with study limitations rather than producing thin summaries.

Peptides / stacks that act on this

Review our site's disclaimer for the full scope of how research content is framed on this site, including the basis on which information is provided and the populations for whom it is and is not intended.

Reading tip

YMYL classification is topic-based, not domain-based. A single page discussing peptide administration protocols on an otherwise general health blog is assessed as YMYL content regardless of the domain's overall focus. There is no "safe" domain from which to publish YMYL content without E-E-A-T requirements — quality standards apply at the page level.